36 reports of this reaction
2.1% of all PYRITHIONE ZINC reports
#7 most reported adverse reaction
SKIN EXFOLIATION is the #7 most commonly reported adverse reaction for PYRITHIONE ZINC, manufactured by Wal-Mart Stores Inc. There are 36 FDA adverse event reports linking PYRITHIONE ZINC to SKIN EXFOLIATION. This represents approximately 2.1% of all 1,712 adverse event reports for this drug.
Patients taking PYRITHIONE ZINC who experience skin exfoliation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SKIN EXFOLIATION is a less commonly reported adverse event for PYRITHIONE ZINC, but still significant enough to appear in the safety profile.
In addition to skin exfoliation, the following adverse reactions have been reported for PYRITHIONE ZINC:
The following drugs have also been linked to skin exfoliation in FDA adverse event reports:
SKIN EXFOLIATION has been reported as an adverse event in 36 FDA reports for PYRITHIONE ZINC. This does not prove causation, but indicates an association observed in post-market surveillance data.
SKIN EXFOLIATION accounts for approximately 2.1% of all adverse event reports for PYRITHIONE ZINC, making it a notable side effect.
If you experience skin exfoliation while taking PYRITHIONE ZINC, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.